116 related articles for article (PubMed ID: 22466918)
1. Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.
Lopez-Delgado JC; Mendiluce RM; Pinol TS; Fernández XP; Sanchez L; Vicente RG
Ann Transplant; 2012; 17(1):122-7. PubMed ID: 22466918
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
[TBL] [Abstract][Full Text] [Related]
3. Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantation.
Jao J; Sturdevant M; del Rio Martin J; Schiano T; Fiel MI; Huprikar S
Am J Transplant; 2010 Jul; 10(7):1713-6. PubMed ID: 20642694
[TBL] [Abstract][Full Text] [Related]
4. Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
Elsharkawy AM; Schwab U; McCarron B; Burt AD; Daly AK; Hudson M; Masson S
J Clin Virol; 2013 Sep; 58(1):331-3. PubMed ID: 23763943
[TBL] [Abstract][Full Text] [Related]
5. [Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)].
Vennarecci G; Ettorre GM; Antonini M; Maritti M; Moricca P; D'Offizzi G; Narciso P; Lonardo MT; Boschetto A; Del Nonno F; Perracchio L; Palmieri GP; Visco G; Santoro E
Tumori; 2003; 89(4 Suppl):159-61. PubMed ID: 12903579
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic failure due to nevirapine treatment for HIV infection].
Mens H; Katzenstein TL
Ugeskr Laeger; 2005 Nov; 167(46):4359. PubMed ID: 16287519
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Sha BE; Proia LA; Kessler HA
JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
[No Abstract] [Full Text] [Related]
8. A paediatric case of acute liver failure associated with efavirenz-based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation.
Turkova A; Ball C; Gilmour-White S; Rela M; Mieli-Vergani G
J Antimicrob Chemother; 2009 Mar; 63(3):623-5. PubMed ID: 19164417
[No Abstract] [Full Text] [Related]
9. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
[TBL] [Abstract][Full Text] [Related]
10. Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: a case report and review of literature.
Wang B; Abbott L; Childs K; Taylor C; Agarwal K; Cormack I; Miquel R; Suddle A
Int J STD AIDS; 2018 Mar; 29(4):414-417. PubMed ID: 29059031
[TBL] [Abstract][Full Text] [Related]
11. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
[No Abstract] [Full Text] [Related]
12. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
[TBL] [Abstract][Full Text] [Related]
13. Nevirapine-induced fulminant hepatitis.
Maniar JK; Shah SR; Verma R; Kamath R; Gupte P; Maniar A
J Assoc Physicians India; 2006 Dec; 54():957-8. PubMed ID: 17334017
[TBL] [Abstract][Full Text] [Related]
14. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
Sulkowski MS; Thomas DL; Mehta SH; Chaisson RE; Moore RD
Hepatology; 2002 Jan; 35(1):182-9. PubMed ID: 11786975
[TBL] [Abstract][Full Text] [Related]
16. Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases.
Clark SJ; Creighton S; Portmann B; Taylor C; Wendon JA; Cramp ME
J Hepatol; 2002 Feb; 36(2):295-301. PubMed ID: 11830344
[TBL] [Abstract][Full Text] [Related]
17. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
Bundow D; Rosoff L; Aboulafia DM
AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
Popoola TD; Awodele O; Oshikoya KA
Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan.
Tseng YT; Yang CJ; Chang SY; Lin SW; Tsai MS; Liu WC; Wu PY; Su YC; Luo YZ; Yang SP; Hung CC; Chang SC
Int J Infect Dis; 2014 Dec; 29():12-7. PubMed ID: 25312984
[TBL] [Abstract][Full Text] [Related]
20. Oral adverse effects due to the use of Nevirapine.
Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
